Biotech Analysts Stavropoulos and Kluska, along with Dr. Gideon Hirschfield of the University of Toronto, discuss emerging therapies for primary sclerosing cholangitis and primary biliary cholangitis (relevant companies PLRX and CBAY) on an Analyst/Industry conference call to be held on May 5 at 11 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PLRX:
- Cantor biopharma/biotech analysts to hold an analyst/industry conference call
- Baird starts Pliant Therapeutics at Outperform, sees bexotegrast as promising
- Pliant Therapeutics initiated with an Outperform at Baird
- Pliant Therapeutics to Participate in the 22nd Annual Needham Healthcare Conference
- 3 Best Stocks to Buy Now, 3/28/2023, According to Top Analysts